Tenaya Therapeutics, Inc.

Stocks

TNYA

US87990A1060

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-17 pm EDT			5-day change	1st Jan Change
0.8170 ^USD	-2.46%		-6.14%	+14.83%

Jun. 29	Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026	CI
Jun. 29	Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026	CI

Transcript : Tenaya Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 01

Published on 03/18/2026 at 07:48 am EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Unknown Analyst (Analysts)

Thank you to the -- and welcome back to our next session of the Global Healthcare Conference here in sunny Miami. I guess I'm hosting everyone in more than

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Tenaya Therapeutics, Inc.

Jun. 29	Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026	CI
Jun. 29	Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026	CI
Jun. 29	Tenaya Therapeutics Names Eric Hyllengren CFO	MT
Jun. 05	Tenaya Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 03:10 PM
Jun. 03	Tenaya Therapeutics, Inc. - Special Call
Jun. 02	Tenaya Therapeutics, Inc. Announces New Interim Data From MyPEAK-1 Phase 1b/2 Trial Of TN-201 For Adults With MYBPC3-Associated HCM	CI
May. 15	Tenaya Therapeutics, Inc. - Special Call
May. 15	Positive interim data from cohorts 1 and 2 of Tenaya's Ridge-1 phase 1b/2 clinical trial of TN-401	RE
May. 15	Tenaya Therapeutics Presents Interim Data From Ridge-1 Phase 1b/2 Clinical Trial Of TN-401 Gene Therapy For PKP2-Associated ARVC	CI
May. 06	Tenaya Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 27	Tenaya Therapeutics Announces New Clinical Data and Pipeline Innovations	CI
Mar. 18	Tenaya Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 01:00 PM
Mar. 11	Tenaya Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 09	Tenaya Therapeutics Presents Preclinical Data Highlighting Tn-301?S Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy	CI
Mar. 05	Tenaya Therapeutics and Alnylam Pharmaceuticals Enter Research Collaboration Agreement	CI